Mary C. Tanner | |
---|---|
Born | October 10, 1951 |
Alma mater | Harvard University |
Spouse | Frederick Frank[1][2][3] |
Scientific career | |
Fields | Investment banking, biotechnology |
Institutions | EVOLUTION Life Science Partners, Peter J. Solomon Company, Lehman Brothers |
Mary Catherine Tanner is an investment banker, with more than 25 years of experience on Wall Street. She specializes in the areas of biotechnology, pharmaceuticals, and health care services.[4][5] Her expertise includes ethical pharmaceuticals and green technology.[1] Fluent in both English and French, she specializes in cross-border transactions between large and small companies, corporate partnering and minority investments.[4][5]
As of 2014, Tanner was Senior Managing Director of EVOLUTION Life Science Partners (ELSP), and a co-founder and chair of Life Science Partners LLP. Previously she served as Senior Managing Director of Lehman Brothers, Bear Stearns, and the Peter J. Solomon Company.[4][5] Tanner was the first woman to become a partner at Lehman Brothers.[6] She is credited with directing over 130 IPOs for life sciences organizations,[5] and over 500 mergers and acquisitions.[4]
Tidmarsh
was invoked but never defined (see the help page).Bloomberg
was invoked but never defined (see the help page).